Home

CPMG Inc

CIK 1372218 · last filed 2024-05-07

CPMG Inc is a corporate insider who has filed 32 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for PRCT, was dated May 7, 2024. Across all open-market trades the lifetime net is +$99.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $437.0M across reported positions. The firm reports its address in Dallas, TX. 18 SEC filings were submitted jointly with Edward W. Rose III.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$436.97M

Companies

4

Total Filings

32

Lifetime Open-Market Net

$99.43M

Filer Profile

Reported Address
4215 WEST LOVERS LANE
SUITE 100
DALLAS, TX 75209
Phone
(214) 871-6816
State of Incorporation
TX
Related Filers
Edward W. Rose III — 18 joint filings, latest 2007-06-13
Cardinal Investment Co Inc Profit Sharing Plan — 13 joint filings, latest 2007-05-29
R Kent McGaughy Jr — 8 joint filings, latest 2024-05-07
White Tailed Ptarmigan, LP — 8 joint filings, latest 2024-05-07
Antal Rohit Desai — 3 joint filings, latest 2023-09-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRCT 10%+ Owner 2,828,204 $19.30 $54.58M $33.00M 4 2024-05-07
Apollo Endosurgery, Inc. (APEN) Delisted 10%+ Owner 0 $10.00 $0 $7.53M 4 2023-04-04
REATA PHARMACEUTICALS INC (RETA) Delisted Director 5,577 $172.36 $961.3K $47.62M 18 2020-12-29
GTOP 10%+ Owner 7,889,947 $48.47 $382.39M $11.28M 4 2007-06-13

Recent Filings

32 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-05-07 PRCT Other (J) −5,355,381 $0 EDGAR
2023-09-28 — Disp (D) −5,856,736 $0
2023-04-04 Apollo Endosurgery, Inc. (APEN) Delisted Disp (D) −12,367,206 $0 EDGAR
2022-11-16 PRCT Other (J) −5,188,446 $0 EDGAR
2022-09-13 PRCT Other (J) −2,959,920 $0 EDGAR
2021-10-19 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +683,871 $5.30M EDGAR
2021-09-21 PRCT Mixed +31,574,730 $33.00M EDGAR
2020-12-29 REATA PHARMACEUTICALS INC (RETA) Delisted Other (J) −166,666 $0 EDGAR
2020-07-21 Apollo Endosurgery, Inc. (APEN) Delisted Buy (P) +1,780,000 $2.23M EDGAR
2020-01-06 Apollo Endosurgery, Inc. (APEN) Delisted Other (J) +57,163 $0 EDGAR
Showing 1–10 of 32
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.